GE Healthcare received its second warning letter in 2007, this time related to its diagnostic X-ray devices, just three weeks before it planned to notify the FDA that it was working to address manufacturing issues identified in a separate warning letter for its MRI coil and breast biopsy plate operations. The most recent warning letter, issued Nov. 16, concerns two diagnostic X-ray devices that deviated from performance standards.
